logo

For the Inventor, By the Inventor

Chelmer, Australia

Robert C Reid

This inventor holds 8 USPTO granted patents and 1 EPO patent. Top assignees: The University of Queensland, Other. Active years: 1994-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert C Reid. Retrieved from https://idiyas.com/inventor/robert-c-reid-8l865xfz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 29(Granted Patents)


Location History:

  • Crows Nest, New South Wales, 2065, AU (1994)
  • Browns Plains, AU (2000)
  • Chelmer, AU (2007 - 2017)
  • Brisbane, AU (2015 - 2018)

Company Filing History:

goldMedal7 out of 345 
 
The University of Queensland
 patents
silverMedal1 out of 834,601 
Other
 patents

Years Active: 1994-2026

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 12637433 - Histone deacetylase inhibitors (2026-05-26),
2. 9868763 - Modulators of protease activated receptors (2018-01-16),
3. 9701711 - Modulators of protease activated receptors (2017-07-11),
4. 9586914 - Modulators of C3a receptors (2017-03-07),
5. 8927503 - Modulations of protease activated receptors (2015-01-06),
6. 7253194 - Compounds and inhibitors of phospholipases (2007-08-07),
7. 6043357 - HIV protease inhibitors (2000-03-28),
8. 5337532 - Concrete floor system (1994-08-16),

Title: Innovations and Contributions of Inventor Robert C Reid

Introduction

Robert C Reid is a notable inventor based in Chelmer, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for therapeutic applications. With a total of seven patents to his name, Reid's work has the potential to impact various medical conditions.

Latest Patents

Reid's latest patents include innovative compounds that act as modulators of protease activated receptors. The first patent provides novel compounds of the Formula (I), along with pharmaceutical compositions that utilize these compounds. These inventions are designed for biological studies and therapeutic applications targeting metabolic syndrome, obesity, type II diabetes, fibrosis, and cardiovascular diseases. The second patent focuses on compounds that modulate Protease Activated Receptor-2 (PAR2), offering potential treatments for individuals at risk of or suffering from disorders associated with undesirable PAR2 activity.

Career Highlights

Throughout his career, Robert C Reid has worked with esteemed institutions, including The University of Queensland. His research and innovations have contributed to advancements in medical therapies and drug development.

Collaborations

Reid has collaborated with notable colleagues such as David P Fairlie and Ligong Liu, enhancing the scope and impact of his research endeavors.

Conclusion

Robert C Reid's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic options for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…